Intradermal sterile water injection versus diclofenac sodium in acute renal colic pain: A randomized controlled trial.


Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
06 2021
Historique:
received: 07 04 2020
revised: 14 04 2020
accepted: 24 04 2020
pubmed: 24 5 2020
medline: 22 6 2021
entrez: 24 5 2020
Statut: ppublish

Résumé

We aimed to evaluate the efficacy of intracutaneous sterile water injection (ISWI) to relieve the pain of acute renal colic compared with diclofenac and placebo. The study included 150 patients presented to the Emergency Department with renal colic randomized into 3 groups: control group received intracutaneous injections of 0.5 cm The mean baseline pain score was 9.6 ± 0.61 in the ISWI group, 9.72 ± 0.64 in the diclofenac group and 9.26 ± 0.89 in the control group. The mean pain score at 30 min of the control group was reduced to 6.9 ± 1.56. This mean at 30 min after ISWI and diclofenac injections were reduced to 1.98 ± 1.41 and 1.88 ± 1.19 respectively. The mean of pain sore of the ISWI and diclofenac group at 45 and 60 min was constant. Rescue analgesics at 1 h were required by 47 patients receiving the saline injection and by 4 patients and by 7 patients receiving ISWI and diclofenac injection respectively. ISWI and diclofenac were equally effective for the pain relief of acute renal colic.

Identifiants

pubmed: 32444296
pii: S0735-6757(20)30309-0
doi: 10.1016/j.ajem.2020.04.079
pii:
doi:

Substances chimiques

Anti-Inflammatory Agents, Non-Steroidal 0
Contrast Media 0
Water 059QF0KO0R
Diclofenac 144O8QL0L1

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

395-400

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no competing interests.

Auteurs

Mohamad Moussa (M)

Head of Urology Department, Zahraa Hospital, University Medical Center, Lebanese University, Beirut, Lebanon.

Athanasios G Papatsoris (AG)

2nd Department of Urology, School of Medicine, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Mohamed Abou Chakra (MA)

Faculty of Medical Sciences, Department of Urology, Lebanese University, Beirut, Lebanon. Electronic address: mohamedabouchakra@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH